SLN – silence therapeutics plc - american depository share (US:NASDAQ)
Stock Stats
News
Silence Therapeutics plc (NASDAQ: SLN) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $45.00 price target on the stock.
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains? [Yahoo! Finance]
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) [Yahoo! Finance]
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
Silence Therapeutics plc (NASDAQ: SLN) had its price target raised by analysts at Chardan Capital from $26.00 to $42.00. They now have a "buy" rating on the stock.
Form 6-K Silence Therapeutics For: Apr 15
Form SC 13D/A Silence Therapeutics Filed by: Griffiths Richard Ian
Form 20-F Silence Therapeutics For: Dec 31
Form 6-K Silence Therapeutics For: Mar 13
Form 6-K Silence Therapeutics For: Feb 23
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.